Clinical Trial

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-03-31 -> 2027-03-31 2026-04-09
minor Completion pushed: 2026-05-31 -> 2027-05-31 2026-04-09
Trial Details
NCT Number NCT06487533
Lead Sponsor Spark Biomedical, Inc.
Collaborators: Battelle Memorial Institute, Hazelden Betty Ford Foundation, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), The HEAL Initiative
Conditions Opioid Withdrawal, Opioid Use Disorder
Enrollment 20 participants
Start Date 2025-02-19
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-02